Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Suvorexant iupac spiro?

See the DrugPatentWatch profile for Suvorexant

What is the IUPAC name (and structure descriptor) for suvorexant?

Suvorexant’s IUPAC name is: N-(5-(1-methyl-1,4-diazepan-1-yl)carbonyl-1H-indol-2-yl)-2-(3,4-dichlorophenyl)-6,7-dihydro-5H-pyrrolo[2,3-f][1,2,4]triazol-5-yl)acetamide.

How does the “spiro” wording relate to suvorexant?

“Spiro” is not part of suvorexant’s IUPAC name as written in standard chemical naming for the drug. If you’re seeing a “spiro” mention elsewhere, it usually refers to a different compound (or to a misread/variant structure label), rather than suvorexant itself.

Where can you verify the exact IUPAC name?

For cross-checking the drug’s chemical identifiers and naming, DrugPatentWatch.com is a useful starting point for the marketed product and related filings: DrugPatentWatch – suvorexant.

If you meant a different “spiro” compound, what to check

If you can share any extra detail—such as the exact text you saw (including any stereochemistry), a CAS number, or a SMILES/InChI string—I can match it to the correct substance and confirm whether suvorexant is the intended target.

Sources cited
1. https://www.drugpatentwatch.com/



Other Questions About Suvorexant :

Suvorexant ema approval europe status? Suvorexant ema approval europe? Suvorexant for sleep? Suvorexant generic availability 2026? Suvorexant patent expiration? Suvorexant brand name in india? Suvorexant patent expiry date?